Chasm Partners, an executive search firm in the healthcare technology and services space recently convened a roundtable discussion to assess how the transformation of “big data” in clinical informatics provides the healthcare industry with an opportunity to gain new insights into patient care, as well as key lessons learned about artificial intelligence’s impact on the industry.Hosted as part of the firm’s quality newsletter, ChasmPOV featured viewpoints from three recognized thought leaders in
Read More
HMS’ Jennifer Forster Talks Leveraging Social Determinants of Health to Improve Population Health Outcomes
HMS’ Jennifer Forster explains how payers can cut costs and improve population health outcomes by incorporating social determinants of health (SDoH) into the mix.While the future of precision medicine is often associated with advances in genomics, there is more to consider when it comes to developing personalized treatment and PHM efforts. In fact, considering social determinants of health (SDoH), a recent and growing trend in predictive analytics, is gaining traction.A new study in Population
Read More
Hospital Culture: 4 Best Practices for Evidence-based Medicine Adoption
Does your organization follow evidence-based care guidelines? Do you currently utilize evidence-based content in your EHR? Do your clinicians embrace practices based on the best and most current clinical evidence?If your hospital has not yet fully adopted evidence-based medicine, yet wants to move in that direction, an important first step is to assess your organization’s readiness, starting with an examination of the hospital’s culture. As I travel across the country in my job, I often
Read More
Report: Precision Medicine Market Share to Cross $96B by 2024
The Precision Medicine Market size is set to exceed $96 billion dollars by 2024; according to a new research report by Global Market Insights. The new report reveals the rising prevalence of cancer across the globe fueling the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size.Advancement in cancer biology coupled with increased funding for cancer research will fuel industry
Read More
hc1.com Raises $10M to Expand Precision Health Platform for Value-based Care
hc1.com, an Indianapolis, IN-based precision medicine startup, announced that existing investor Health Cloud Capital has exercised its option to provide additional growth funding, bringing the company’s total Series B capital raise to $10 million. Elevate Ventures also participated in the round. The additional capital will fund continued expansion of precision health initiatives underway at hc1, including solutions that combat the opioid crisis and optimize prescribing of other prescription
Read More
Akouos Raises $50M to Advance Precision Medicine for Hearing Disorders
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Enterprise Associates (NEA) with participation from existing investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund. The company plans to use the funding round to advance its lead program to first-in-human clinical trials and bolster its
Read More
Click Therapeutics Lands $17M to Advance Prescription Digital Therapeutics Platform
Click Therapeutics, Inc. (“Click”), a provider of Digital Therapeutics solutions as prescription medical treatments, has raised $17 million in funding led by Sanofi Ventures, the corporate venture capital arm of Sanofi. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Among these areas are rare diseases, vaccines, potential cures in other core areas of Sanofi’s
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
Syapse Precision Medicine Council Launches to Advance Precision Oncology Adoption
Syapse, a San Francisco, CA-based precision medicine company, announced today the formation of the Syapse Precision Medicine Council, a group of oncology, operations, and research leaders from health systems dedicated to advancing precision oncology adoption through sharing best practices.Inaugural members include Henry Ford Health System, Catholic Health Initiatives and Dignity Health (the Precision Medicine Alliance), Providence St. Joseph Health, Aurora Health Care, and the University of
Read More
5 Ways SmartTrials is Advancing Precision Medicine Through Genomics
Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More